1.Wrigley, BJ, Lip, GY and Shantsila, E.The role of monocytes and inflammation in the pathophysiology of heart failure. Eur J Heart Fail 2011; 13: 1161–1171.
2.Weir, RA, Miller, AM, Petrie, CJet al.Interleukin-21--a biomarker of importance in predicting myocardial function following acute infarction? Cytokine 2012; 60: 220–225.
3.Mann, DL.Innate immunity and the failing heart: the cytokine hypothesis revisited. Circ Res 2015; 116: 1254–1268.
4.Fertin, M, Dubois, E, Belliard, A, Amouyel, P, Pinet, F and Bauters, C.Usefulness of circulating biomarkers for the prediction of left ventricular remodeling after myocardial infarction. Am J Cardiol 2012; 110: 277–283.
5.Madjid, M, Awan, I, Willerson, JT and Casscells, SW.Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol 2004; 44: 1945–1956.
6.Kaptoge, S, Di Angelantonio, E, Pennells, Let al.C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 2012; 367: 1310–1320.
7.Blake, GJ, Rifai, N, Buring, JE and Ridker, PM.Blood pressure, C-reactive protein, and risk of future cardiovascular events. Circulation 2003; 108: 2993–2999.
8.Pearson, TA, Mensah, GA, Alexander, RWet al.Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499–511.
9.Papa, A, Emdin, M, Passino, C, Michelassi, C, Battaglia, D and Cocci, F.Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease. Clin Chim Acta 2008; 395: 27–31.
10.Azab, B, Zaher, M, Weiserbs, KFet al.Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction. Am J Cardiol 2010; 106: 470–476.
11.Tamhane, UU, Aneja, S, Montgomery, D, Rogers, EK, Eagle, KA and Gurm, HS.Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol 2008; 102: 653–657.10.1016/j.amjcard.2008.05.006
12.Nunez, J, Nunez, E, Bodi, Vet al.Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. Am J Cardiol 2008; 101: 747–752.
13.Gurm, HS, Bhatt, DL, Lincoff, AMet al.Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials. Heart 2003; 89: 1200–1204.
14.Flores, S, Cooper, DS, Opoka, AMet al.Characterization of the glucocorticoid receptor in children undergoing cardiac surgery. Pediatr Crit Care Med 2018; 19: 705–712.
15.Hannan, RL, Ybarra, MA, White, JA, Ojito, JW, Rossi, AF and Burke, RP.Patterns of lactate values after congenital heart surgery and timing of cardiopulmonary support. Ann Thorac Surg 2005; 80: 1468–1473; discussion 1473–1464.
16.Gaies, MG, Gurney, JG, Yen, AHet al.Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass. Pediatr Crit Care Med 2010; 11: 234–238.
17.Silberman, S, Abu-Yunis, U, Tauber, Ret al.Neutrophil-lymphocyte ratio: Prognostic impact in heart surgery. Early outcomes and late survival. Ann Thorac Surg 2018; 105: 581–586.
18.Yost, GL, Joseph, CR, Tatooles, AJ and Bhat, G.Neutrophil-to-lymphocyte ratio predicts outcomes in patients implanted with left ventricular assist devices. Asaio j 2015; 61: 664–669.
19.Uthamalingam, S, Patvardhan, EA, Subramanian, Set al.Utility of the neutrophil to lymphocyte ratio in predicting long-term outcomes in acute decompensated heart failure. Am J Cardiol 2011; 107: 433–438.
20.Polat, N, Yildiz, A, Bilik, MZet al.The importance of hematologic indices in the risk stratification of patients with acute decompensated systolic heart failure. Turk Kardiyol Dern Ars 2015; 43: 157–165.
21.Huang, WM, Cheng, HM, Huang, CJet al.Hemographic indices are associated with mortality in acute heart failure. Sci Rep 2017; 7: 17828.
22.Cooper, HA, Exner, DV, Waclawiw, MA and Domanski, MJ.White blood cell count and mortality in patients with ischemic and nonischemic left ventricular systolic dysfunction (an analysis of the Studies Of Left Ventricular Dysfunction [SOLVD]). Am J Cardiol 1999; 84: 252–257.
23.Huehnergarth, KV, Mozaffarian, D, Sullivan, MDet al.Usefulness of relative lymphocyte count as an independent predictor of death/urgent transplant in heart failure. Am J Cardiol 2005; 95: 1492–1495.
24.Shah, AD, Denaxas, S, Nicholas, O, Hingorani, AD and Hemingway, H.Neutrophil counts and initial presentation of 12 cardiovascular diseases: A CALIBER cohort study. J Am Coll Cardiol 2017; 69: 1160–1169.
25.Briasoulis, A, Androulakis, E, Christophides, T and Tousoulis, D.The role of inflammation and cell death in the pathogenesis, progression and treatment of heart failure. Heart Fail Rev 2016; 21: 169–176.
26.Frangogiannis, NG.Regulation of the inflammatory response in cardiac repair. Circ Res 2012; 110: 159–173.
27.Frangogiannis, NG.The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol 2014; 11: 255–265.
28.Horckmans, M, Ring, L, Duchene, Jet al.Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype. Eur Heart J 2017; 38: 187–197.
29.Brinkmann, V, Reichard, U, Goosmann, Cet al.Neutrophil extracellular traps kill bacteria. Science 2004; 303: 1532–1535.
30.Dalli, J, Montero-Melendez, T, Norling, LVet al.Heterogeneity in neutrophil microparticles reveals distinct proteome and functional properties. Mol Cell Proteomics 2013; 12: 2205–2219.10.1074/mcp.M113.028589
31.Soehnlein, O, Steffens, S, Hidalgo, A and Weber, C.Neutrophils as protagonists and targets in chronic inflammation. Nat Rev Immunol 2017; 17: 248–261.
32.Horne, BD, Anderson, JL, John, JMet al.Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol 2005; 45: 1638–1643.
33.Segel, GB, Halterman, MW and Lichtman, MA.The paradox of the neutrophil’s role in tissue injury. J Leukoc Biol 2011; 89: 359–372.
34.Habib, M, Thawabi, M, Hawatmeh, Aet al.Value of neutrophil to lymphocyte ratio as a predictor of mortality in patients undergoing aortic valve replacement. Cardiovasc Diagn Ther 2018; 8: 164–172.
35.Sliwa, K, Woodiwiss, A, Candy, Get al.Effects of pentoxifylline on cytokine profiles and left ventricular performance in patients with decompensated congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol 2002; 90: 1118–1122.
36.Krum, H, Ashton, E, Reid, Cet al.Double-blind, randomized, placebo-controlled study of high-dose HMG CoA reductase inhibitor therapy on ventricular remodeling, pro-inflammatory cytokines and neurohormonal parameters in patients with chronic systolic heart failure. J Card Fail 2007; 13: 1–7.